PharmEasy Stock
Telemedecine Platform
Sign up today and learn more about PharmEasy Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About PharmEasy Stock
PharmEasy is - Pharmacy made Easy. We are one of the largest pharmacy aggregators in India. We help patients connect with local pharmacy stores and diagnostic centres in order to fulfil their extensive medical needs. We believe that everyone should have access to good health.
Investors
Astarc Ventures
B Capital Group
PharmEasy, Bird, Highspot, 6sense, Flutterwave, Clari, Starburst Data, Innovaccer, Newfront Insurance, Icertis
Bessemer Venture Partners
Swiggy, PharmEasy, BigBasket, Pinterest, Snapdeal, Sila Nanotechnologies, ServiceTitan, Toast, Hinge Health, Box
Caisse de Depot et Placement du Quebec
PharmEasy, Bird, AvidXchange, AppDirect, Druva, Hopper, Onapsis
Eight Roads Ventures India
F-Prime Capital Partners
PharmEasy, Devoted Health, Benchling, SonderMind, Prime Medicine, Snapdocs, Flywire, Quartet, Caribou Biosciences, Unison Home Ownership Investors
Fundamentum
InnoVen Capital
Rivigo, MobiKwik, OYO, Ather Energy, Swiggy, PharmEasy, Quikr, ZoomCar, GreyOrange
JM Financial
KB Financial Group
LGT group
Manipal Group
Prosus Ventures
Temasek Holdings
PharmEasy, Tokopedia, Ola, Magic Leap, DoorDash, Impossible Foods, Commonwealth Fusion, Wish, Snyk, AvidXchange
Trifecta Capital Advisors
Funding History
| March 2016 | $5.0M |
|---|---|
| March 2017 | $16.0M |
| April 2017 | $2.0M |
| February 2018 | $2.0B |
| September 2018 | $50.0M |
| September 2018 | $400M |
| November 2019 | $220M |
| April 2021 | $323M |
| June 2021 | $20.0M |
Management
Chief Executive Officer
Dharmil Sheth
Chief Technology Officer
Bhaskar Raju
Press
business-standard - Nov, 18 2023
Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy marketTechCrunch - Nov, 8 2023
Vanguard slashes Ola valuation by 60%-plus; NB reduces Pharmeasy’s by over 90%economictimes - Nov, 1 2023
PharmEasy CEO has three-year lock-in, Ranjan Pai to get three board seatsinc42 - Oct, 31 2023
PharmEasy’s INR 3,500 Cr Rights Issue Oversubscribed, Claims Cofounder Dhaval Shaheconomictimes - Aug, 30 2023
Goldman may convert part-debt into equity in PharmEasyinc42 - Aug, 23 2023
PharmEasy Plans To Raise INR 3,500 Cr Through Right Issuevccircle - Aug, 23 2023
Temasek, TPG, Prosus to invest more in PharmEasy as valuation slumpseconomictimes - Jul, 12 2023
PharmEasy valuation crash may not hit Thyrocare founder Velumani’s stakeforbesindia - Jul, 11 2023
What went wrong at PharmEasy and can it find a cure?vccircle - Jul, 5 2023
Pharmeasy eyes $304 mn in funding from Manipal Group, existing investorsTechCrunch - Jul, 5 2023
PharmEasy, once valued at $5 billion, seeks new funding at a 90% valuation cutyourstory - Jul, 5 2023
PharmEasy wants to raise Rs 2,400 Cr at 90% lower valuation: Reportbit - Jun, 28 2023
PharmEasy has skipped the growth pill for profitability. This may lead to side effectsvccircle - Jun, 19 2023
Co-founder harmony: Pharmeasy’s Parekh weighs in at VCCircle Founders’ Foruminc42 - Jun, 9 2023
PharmEasy Appoints Avendus Capital For Next Funding Roundinc42 - Jun, 2 2023
Janus Henderson Further Cuts PharmEasy’s Valuation To $2.7 Bndealstreetasia - Jun, 1 2023
PharmEasy breaches Goldman loan covenant by failing to raise $120m equity funding: reporteconomictimes - May, 16 2023
PharmEasy logs first ebitda profit of Rs 14 crore in April, restarts funding talksyourstory - May, 16 2023
PharmEasy faces second valuation markdown; looks to raise $50M-$100M: Reportthehindubusinessline - May, 12 2023
Amid funding winter. Neuberger Berman slashes Pine Labs’ and Pharmeasy’s valuationsinc42 - May, 12 2023
Valuation Markdown: Now Pine Labs, PharmEasy Face The Burnyourstory - May, 12 2023
Investor Neuberger Berman slashes valuation in PharmEasy, Pine Labslivemint - May, 11 2023
Pharmeasy charts turnaround, turns cash flow positive Aprtheupreport - May, 4 2023
PharmEasy lays off employees amidst funding strugglesdealstreetasia - May, 2 2023
Temasek-backed healthtech startup PharmEasy latest to lay off employeesinc42 - Mar, 3 2023
BYJU’S, PharmEasy & The Burden Of Startup Acquisitionseconomictimes - Feb, 15 2023
Exclusive | Not selling Thyrocare, will cut cash burn: PharmEasy founders to boardvccircle - Feb, 1 2023
PharmEasy CFO steps down to join Entero Healthentrackr - Dec, 22 2022
PharmEasy’s scale crosses Rs 5,700 Cr in FY22, losses mount 4Xinc42 - Dec, 10 2022
PharmEasy Lays Off More Employees Amid Funding Crunchbit - Nov, 16 2022
"I admit my timing of the market is bad": PharmEasy CEOtechinasia - Nov, 16 2022
Temasek-backed debt financing firm to invest in PharmEasy parentbit - Nov, 13 2022
New course for ailing PharmEasy: Are the troubles terminal or transient?inc42 - Nov, 9 2022
Temasek’s EvolutionX Debt Capital Backs PharmEasybit - Nov, 8 2022
PharmEasy’s parent raises debt fundingbusiness-standard - Oct, 28 2022
Boat joins PharmEasy, Droom to shelve listing plans amid valuation concernsinc42 - Oct, 28 2022
From boAt to PharmEasy: Startup IPO Plans In Disarray As Market Remains Soureconomictimes - Oct, 9 2022
PharmEasy prepares Rs 750 crore funding through convertible noteseconomictimes - Oct, 6 2022
PharmEasy floats rights issue to raise Rs 750 crorestartuparound - Sep, 6 2022
PharmEasy shelves IPO plans, opts for a rights issue insteadbusiness-standard - Aug, 23 2022
PharmEasy listing pull-out a sign of start-up fatigue: Market expertsift - Aug, 22 2022
Institutional investors oppose Esops; PharmEasy drops IPO, targets Ebitda breakevenbloomberg - Aug, 21 2022
TPG-Backed PharmEasy Owner Withdraws India IPO Applicationeconomictimes - Aug, 20 2022
PharmEasy pulls out market listing planlivemint - Aug, 17 2022
Cashfree Payments partners PharmEasy to facilitate payment settlementsbusiness-standard - Jul, 19 2022
PharmEasy plans $200 million fund raising at lower valuation: Reportinc42 - Jun, 17 2022
Exclusive: IPO-Bound PharmEasy Lays Off 40 Employees From Subsidiary Docon Technologieseconomictimes - May, 18 2022
Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parentlivemint - May, 1 2022
Pharmeasy in talks with PE firms to raise $250 mn debtndtv - Feb, 24 2022
IPO Alert! 3 Companies Including PharmEasy Get The Green Lighteconomictimes - Feb, 22 2022
PharmEasy not in pink of health, shares drop 50% in unlisted marketlivemint - Feb, 21 2022
PharmEasy parent gets SEBI nod for Rs6,250 crore IPOlivemint - Feb, 21 2022
Sebi approves three IPOs including PharmEasyift - Feb, 18 2022
BharatPe saga just won’t quit; PharmEasy may revise IPO valuationyourstory - Feb, 18 2022
PharmEasy may delay IPO in the face of a volatile marketeconomictimes - Feb, 18 2022
PharmEasy may have to rework IPO valuation as street mood swingsmedianama - Dec, 26 2021
Chemist association drags CCI and SEBI to court over PharmEasy’s IPOsiliconindia - Dec, 23 2021
Vakrangee Upsurges after Merging with PharmEasymedianama - Dec, 21 2021
PharmEasy IPO: Here’s why CAIT is asking SEBI to reject the offerthe-captable - Dec, 20 2021
What IPO papers reveal about PharmEasy’s complex structurebusinessinsider - Dec, 15 2021
After chemists’ body, traders demand rejection of PharmEasy’s IPOeconomictimes - Nov, 30 2021
Tata-owned 1mg, PharmEasy go offline for omnichannel presenceinc42 - Nov, 26 2021
IPO-Bound PharmEasy’s Unlisted Share Prices Fall 15% In A Weekmedianama - Nov, 19 2021
Why a Chemist association has asked SEBI to reject the PharmEasy IPObit - Nov, 19 2021
PharmEasy employees hold options worth at least $575 mn; founder ESOP pool to double post listinginc42 - Nov, 14 2021
Org Chart: The People With Power At IPO-Bound PharmEasyinc42 - Nov, 14 2021
PharmEasy & Its Subsidiaries Engaged In 117 Litigations Worth INR 157 Crinc42 - Nov, 13 2021
A Look At the Shareholding Pattern Of IPO Bound PharmEasyentrackr - Nov, 13 2021
Diagnosing the PharmEasy DRHPinc42 - Nov, 13 2021
About 31% Of PharmEasy’s IPO Proceeds To Go Towards Debt Repaymentmybs - Nov, 12 2021
Early mover advantage and scale key themes for PharmEasy investorsinc42 - Nov, 12 2021
IPO-Bound PharmEasy’s Loss Widened To INR 641.3 Cr, Revenue Soared To INR 2,360 Crdealstreetasia - Nov, 12 2021
Online medical store PharmEasy files for $842m India IPOvccircle - Nov, 12 2021
PharmEasy founders pivoted thrice to make it bigvccircle - Oct, 23 2021
Weekly Deals Wrap: Companies raise $986.4 mn this week; unicorns PharmEasy, Cred top chartentrackr - Oct, 21 2021
PharmEasy creates new ESOP pool worth Rs 592 Cr for founders and employeesvccircle - Oct, 20 2021
PharmEasy secures $350 mn in pre-IPO round at $5.6 bn valuation: Reportift - Oct, 20 2021
Ecomm sales boom in festive season; PharmEasy raises $350 millionift - Oct, 6 2021
Exclusive: PharmEasy’s new backers; Facebook whistleblower revealedthe-ken - Oct, 6 2021
IPO-bound PharmEasy’s theory of healthtech: Unified or confused?yourstory - Sep, 19 2021
[The Turning Point] From multiple pivots to an investor backing out, how unicorn PharmEasy found its nichevccircle - Sep, 18 2021
Weekly Deals Wrap: Byju's, PharmEasy, others pump up total transaction valueyourstory - Sep, 16 2021
PharmEasy on hiring, new appointments, and acquisitionsift - Sep, 15 2021
NFTs power metaverse boom; PharmEasy to raise $200M before IPOift - Sep, 15 2021
Pre-IPO bout to value PharmEasy at $6 billionvccircle - Sep, 14 2021
Market-bound PharmEasy buys Lightrock-backed healthcare supply chain Aknamedlivemint - Sep, 13 2021
In run up to IPO, PharmEasy parent appoints 5 independent directors to boardlivemint - Sep, 13 2021
PharmEasy to hire 200 engineers for new development centresinc42 - Sep, 13 2021
IPO-Bound Healthtech Startup PharmEasy Appoints 5 Independent Directorsdlvr - Sep, 12 2021
From Byju’s to Ola to PharmEasy — A look at India’s most valued startupseconomictimes - Aug, 27 2021
PharmEasy plans to file IPO papers by Octoberift - Aug, 27 2021
PharmEasy IPO; the acquihiring trend; D2C brands make hayinc42 - Aug, 11 2021
Pharmeasy To Raise $1 Bn Via IPO, Will File DRHP In October: Reportthe-ken - Jul, 30 2021
The PharmEasy-Thyrocare jinx on the Metropolis-Hitech dealthe-captable - Jul, 29 2021
Unpacking the rise of PharmEasy and its unconventional Thyrocare dealbit - Jul, 12 2021
PharmEasy adds another firm to its shopping list ahead of IPOtechcircle - Jul, 9 2021
Deal Roundup: PharmEasy, Ola, Pine Labs lead $1.9 bn technology startup funding rallyift - Jun, 17 2021
PharmEasy valued at $1.8 billion as B Capital buys stake for $20 millionmybs - May, 31 2021
Ananth Narayanan starts Mensa Brands after exit from PharmEasy-Medlife dealift - May, 29 2021
B Capital, Tiger Global eye PharmEasy stakeinc42 - May, 27 2021
PharmEasy Plans To Raise $500 Mn Through IPO This yearthetechportal - May, 25 2021
Pharmeasy acquires Medlife to create India’s largest medicine delivery platforminc42 - May, 25 2021
All You Need To Know About MedLife’s Merger With PharmEasyindianweb2 - Mar, 16 2021
PharmEasy Launches 'Go Corona Go' Initiative to Empower Vaccine Takerstechcircle - Mar, 4 2021
PharmEasy mops up half of startup funding in subdued dealmaking weekbit - Feb, 23 2021
Exclusive: PharmEasy raises Rs 120 crore from Temasek, Lightstonetechcircle - Dec, 30 2020
TPG gets regulatory approval for stake buy in PharmEasy holding cotechinasia - Nov, 19 2020
India’s digital potential is staggering, but access remains limitedinc42 - Nov, 16 2020
PharmEasy To Buyback ESOPs Worth $3 Mn, Move To Benefit 45 Employeestech - Oct, 9 2020
PharmEasy in investment talks with Naspers, TPGbusinesswireindia - Sep, 18 2020
PharmEasy Goes Live on PhonePe Switch Enabling Online Delivery of Medicines for Millions of Userstechcircle - Aug, 26 2020
CCI approves Lightstone Fund’s stake acquisition in PharmEasybit - Aug, 11 2020
PharmEasy makes formal move to buy Bengaluru-based peerinc42 - Jul, 21 2020
Medlife, PharmEasy Eye Merger As Healthtech Booms During Pandemicinc42 - Aug, 10 2019
Pharmeasy Cofounder Dharmil Sheth Turns Investor For Wife’s Edtech StartupEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
